GMO GlobalSign Holdings K.K. (TYO:3788)

Revance Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,488	8,459	6,655	6,679	4,590	4,670
Short-Term Investments	-	-	-	-	450	600
Cash & Short-Term Investments	8,488	8,459	6,655	6,679	5,040	5,270
Cash Growth	0.44%	27.11%	-0.36%	32.52%	-4.36%	12.53%
Receivables	2,334	2,453	2,194	2,024	1,583	1,333
Prepaid Expenses	789	760	680	603	415	380
Other Current Assets	296	276	534	580	479	407
Total Current Assets	11,907	11,948	10,063	9,886	7,517	7,390
Property, Plant & Equipment	1,019	1,107	1,093	904	783	845
Long-Term Investments	787	777	815	803	1,051	967
Other Intangible Assets	4,025	4,113	3,650	2,792	2,082	1,725
Long-Term Deferred Tax Assets	87	80	71	187	77	134
Other Long-Term Assets	3	2	1	2	2	2
Total Assets	17,828	18,027	15,693	14,574	11,512	11,063
Accounts Payable	66	24	47	68	62	110
Accrued Expenses	665	80	69	104	46	63
Short-Term Debt	-	-	-	1,000	500	300
Current Portion of Long-Term Debt	890	770	400	160	-	-
Current Portion of Leases	117	119	104	72	77	89
Current Income Taxes Payable	935	1,060	995	1,078	752	796
Other Current Liabilities	2,963	3,550	3,170	2,823	2,466	2,142
Total Current Liabilities	5,636	5,603	4,785	5,305	3,903	3,500
Long-Term Debt	1,907	1,842	1,260	585	-	-
Long-Term Leases	254	285	241	140	116	134
Long-Term Deferred Tax Liabilities	648	705	641	495	268	-
Other Long-Term Liabilities	110	106	102	94	74	142
Total Liabilities	8,555	8,541	7,029	6,619	4,361	3,776
Common Stock	916	916	916	916	916	916
Additional Paid-In Capital	-	-	-	-	-	45
Retained Earnings	6,982	6,995	6,584	6,294	5,867	6,027
Treasury Stock	-263	-263	-163	-163	-163	-163
Comprehensive Income & Other	1,612	1,812	1,300	887	512	169
Total Common Equity	9,247	9,460	8,637	7,934	7,132	6,994
Minority Interest	26	26	27	21	19	293
Shareholders' Equity	9,273	9,486	8,664	7,955	7,151	7,287
Total Liabilities & Equity	17,828	18,027	15,693	14,574	11,512	11,063
Total Debt	3,168	3,016	2,005	1,957	693	523
Net Cash (Debt)	5,320	5,443	4,650	4,722	4,347	4,747
Net Cash Growth	-2.35%	17.05%	-1.52%	8.63%	-8.43%	7.89%
Net Cash Per Share	462.79	472.71	403.67	409.92	377.36	412.09
Filing Date Shares Outstanding	11.48	11.48	11.52	11.52	11.52	11.52
Total Common Shares Outstanding	11.48	11.48	11.52	11.52	11.52	11.52
Working Capital	6,271	6,345	5,278	4,581	3,614	3,890
Book Value Per Share	805.37	823.92	749.78	688.75	619.13	607.15
Tangible Book Value	5,222	5,347	4,987	5,142	5,050	5,269
Tangible Book Value Per Share	454.81	465.70	432.92	446.38	438.39	457.40

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.